Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 23NIH 5NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma 27Leukemia 16Lung Neoplasms 13Neuroblastoma 12Burkitt Lymphoma 11Lymphoma, Large B-Cell, Diffuse 10Hodgkin Disease 10Sarcoma 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Central Nervous System Neoplasms 9Brain Neoplasms 9Teratoma 8Carcinoma, Non-Small-Cell Lung 7Wilms Tumor 6Neuroectodermal Tumors, Primitive, Peripheral 6Leukemia, Myeloid, Acute 6Testicular Neoplasms 5Lymphoma, Non-Hodgkin 5Ovarian Neoplasms 4Medulloblastoma 4Lymphoma, Follicular 4Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Endodermal Sinus Tumor 4Dendritic Cell Sarcoma, Interdigitating 4Carcinoma, Embryonal 4Sarcoma, Ewing 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Vincristine 6Radiotherapy 5Prednisone 5Doxorubicin 5Cyclophosphamide 5Gemcitabine 4Cisplatin 4Rituximab 3Methotrexate 3Cytarabine 3Crizotinib 3ibritumomab tiuxetan 2Vinorelbine 2Methylprednisolone 2Etoposide 2Drug Therapy 2Dexamethasone 2merphos 1liposomal amphotericin B 1ixabepilone 1imetelstat 1Whole-Body Irradiation 1Watchful Waiting 1Vinblastine 1VAP-cyclo protocol 1Topotecan 1Stem Cell Transplantation 1Standard of Care 1Specimen Handling 1Razoxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Large-Cell, Anaplastic × Etoposide × Clear all
NCT00310128 2016-02-03

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

AIDS Malignancy Consortium

Phase 2 Withdrawn
Lymphoid

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related, Lymphoma, Large-Cell, Anaplastic

NCT00109928 2014-10-01

S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma

SWOG Cancer Research Network

Phase 2 Completed
34 enrolled 9 charts
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡